Xeomin® (incobotulinumtoxinA) is a prescription medication used to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.
Xeomin® contains botulinum toxin type A, a protein purified from the bacterium Clostridium botulinum.
Botulinum toxin type A acts on nerve endings in muscles to prevent muscle fibers from contracting. By reducing these contractions, Xeomin® can temporarily reduce the lines on your forehead between your brows.
Xeomin® was approved by the US Food and Drug Administration (FDA) in July 2011. It is now widely available to patients across the US.